Global Biologics CDMO Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Biologics CDMO market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Biologics CDMO market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics CDMO market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics CDMO market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biologics CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics CDMO, with price, sales quantity, revenue, and global market share of Biologics CDMO from 2020 to 2025.
Chapter 3, the Biologics CDMO competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics CDMO breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Biologics CDMO market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics CDMO.
Chapter 14 and 15, to describe Biologics CDMO sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Biologics CDMO market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics CDMO market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Biologics CDMO market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics CDMO market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biologics CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Biological Agent
- Biosimilar Drug
- Cell Therapy
- Drug Development
- Others
- Lonza Group AG
- Samsung Biologics
- AbbVie
- WuXi Biologics
- Toyobo
- AGC
- Thermo Fisher Scientific
- ICON Plc
- Boehringer Ingelheim
- Fujifilm Diosynth Biotechnologies
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologics CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics CDMO, with price, sales quantity, revenue, and global market share of Biologics CDMO from 2020 to 2025.
Chapter 3, the Biologics CDMO competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics CDMO breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Biologics CDMO market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics CDMO.
Chapter 14 and 15, to describe Biologics CDMO sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics CDMO Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Biological Agent
1.3.3 Biosimilar Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics CDMO Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Cell Therapy
1.4.3 Drug Development
1.4.4 Others
1.5 Global Biologics CDMO Market Size & Forecast
1.5.1 Global Biologics CDMO Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Biologics CDMO Sales Quantity (2020-2031)
1.5.3 Global Biologics CDMO Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Lonza Group AG
2.1.1 Lonza Group AG Details
2.1.2 Lonza Group AG Major Business
2.1.3 Lonza Group AG Biologics CDMO Product and Services
2.1.4 Lonza Group AG Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group AG Recent Developments/Updates
2.2 Samsung Biologics
2.2.1 Samsung Biologics Details
2.2.2 Samsung Biologics Major Business
2.2.3 Samsung Biologics Biologics CDMO Product and Services
2.2.4 Samsung Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Samsung Biologics Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics CDMO Product and Services
2.3.4 AbbVie Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AbbVie Recent Developments/Updates
2.4 WuXi Biologics
2.4.1 WuXi Biologics Details
2.4.2 WuXi Biologics Major Business
2.4.3 WuXi Biologics Biologics CDMO Product and Services
2.4.4 WuXi Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 WuXi Biologics Recent Developments/Updates
2.5 Toyobo
2.5.1 Toyobo Details
2.5.2 Toyobo Major Business
2.5.3 Toyobo Biologics CDMO Product and Services
2.5.4 Toyobo Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Toyobo Recent Developments/Updates
2.6 AGC
2.6.1 AGC Details
2.6.2 AGC Major Business
2.6.3 AGC Biologics CDMO Product and Services
2.6.4 AGC Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AGC Recent Developments/Updates
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Biologics CDMO Product and Services
2.7.4 Thermo Fisher Scientific Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Thermo Fisher Scientific Recent Developments/Updates
2.8 ICON Plc
2.8.1 ICON Plc Details
2.8.2 ICON Plc Major Business
2.8.3 ICON Plc Biologics CDMO Product and Services
2.8.4 ICON Plc Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 ICON Plc Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Biologics CDMO Product and Services
2.9.4 Boehringer Ingelheim Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Boehringer Ingelheim Recent Developments/Updates
2.10 Fujifilm Diosynth Biotechnologies
2.10.1 Fujifilm Diosynth Biotechnologies Details
2.10.2 Fujifilm Diosynth Biotechnologies Major Business
2.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Product and Services
2.10.4 Fujifilm Diosynth Biotechnologies Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS CDMO BY MANUFACTURER
3.1 Global Biologics CDMO Sales Quantity by Manufacturer (2020-2025)
3.2 Global Biologics CDMO Revenue by Manufacturer (2020-2025)
3.3 Global Biologics CDMO Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Biologics CDMO by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Biologics CDMO Manufacturer Market Share in 2024
3.4.3 Top 6 Biologics CDMO Manufacturer Market Share in 2024
3.5 Biologics CDMO Market: Overall Company Footprint Analysis
3.5.1 Biologics CDMO Market: Region Footprint
3.5.2 Biologics CDMO Market: Company Product Type Footprint
3.5.3 Biologics CDMO Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics CDMO Market Size by Region
4.1.1 Global Biologics CDMO Sales Quantity by Region (2020-2031)
4.1.2 Global Biologics CDMO Consumption Value by Region (2020-2031)
4.1.3 Global Biologics CDMO Average Price by Region (2020-2031)
4.2 North America Biologics CDMO Consumption Value (2020-2031)
4.3 Europe Biologics CDMO Consumption Value (2020-2031)
4.4 Asia-Pacific Biologics CDMO Consumption Value (2020-2031)
4.5 South America Biologics CDMO Consumption Value (2020-2031)
4.6 Middle East & Africa Biologics CDMO Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics CDMO Sales Quantity by Type (2020-2031)
5.2 Global Biologics CDMO Consumption Value by Type (2020-2031)
5.3 Global Biologics CDMO Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics CDMO Sales Quantity by Application (2020-2031)
6.2 Global Biologics CDMO Consumption Value by Application (2020-2031)
6.3 Global Biologics CDMO Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Biologics CDMO Sales Quantity by Type (2020-2031)
7.2 North America Biologics CDMO Sales Quantity by Application (2020-2031)
7.3 North America Biologics CDMO Market Size by Country
7.3.1 North America Biologics CDMO Sales Quantity by Country (2020-2031)
7.3.2 North America Biologics CDMO Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Biologics CDMO Sales Quantity by Type (2020-2031)
8.2 Europe Biologics CDMO Sales Quantity by Application (2020-2031)
8.3 Europe Biologics CDMO Market Size by Country
8.3.1 Europe Biologics CDMO Sales Quantity by Country (2020-2031)
8.3.2 Europe Biologics CDMO Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics CDMO Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Biologics CDMO Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Biologics CDMO Market Size by Region
9.3.1 Asia-Pacific Biologics CDMO Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Biologics CDMO Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Biologics CDMO Sales Quantity by Type (2020-2031)
10.2 South America Biologics CDMO Sales Quantity by Application (2020-2031)
10.3 South America Biologics CDMO Market Size by Country
10.3.1 South America Biologics CDMO Sales Quantity by Country (2020-2031)
10.3.2 South America Biologics CDMO Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics CDMO Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Biologics CDMO Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Biologics CDMO Market Size by Country
11.3.1 Middle East & Africa Biologics CDMO Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Biologics CDMO Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Biologics CDMO Market Drivers
12.2 Biologics CDMO Market Restraints
12.3 Biologics CDMO Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics CDMO and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics CDMO
13.3 Biologics CDMO Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics CDMO Typical Distributors
14.3 Biologics CDMO Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics CDMO Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Biological Agent
1.3.3 Biosimilar Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics CDMO Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Cell Therapy
1.4.3 Drug Development
1.4.4 Others
1.5 Global Biologics CDMO Market Size & Forecast
1.5.1 Global Biologics CDMO Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Biologics CDMO Sales Quantity (2020-2031)
1.5.3 Global Biologics CDMO Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Lonza Group AG
2.1.1 Lonza Group AG Details
2.1.2 Lonza Group AG Major Business
2.1.3 Lonza Group AG Biologics CDMO Product and Services
2.1.4 Lonza Group AG Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group AG Recent Developments/Updates
2.2 Samsung Biologics
2.2.1 Samsung Biologics Details
2.2.2 Samsung Biologics Major Business
2.2.3 Samsung Biologics Biologics CDMO Product and Services
2.2.4 Samsung Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Samsung Biologics Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics CDMO Product and Services
2.3.4 AbbVie Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AbbVie Recent Developments/Updates
2.4 WuXi Biologics
2.4.1 WuXi Biologics Details
2.4.2 WuXi Biologics Major Business
2.4.3 WuXi Biologics Biologics CDMO Product and Services
2.4.4 WuXi Biologics Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 WuXi Biologics Recent Developments/Updates
2.5 Toyobo
2.5.1 Toyobo Details
2.5.2 Toyobo Major Business
2.5.3 Toyobo Biologics CDMO Product and Services
2.5.4 Toyobo Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Toyobo Recent Developments/Updates
2.6 AGC
2.6.1 AGC Details
2.6.2 AGC Major Business
2.6.3 AGC Biologics CDMO Product and Services
2.6.4 AGC Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AGC Recent Developments/Updates
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Biologics CDMO Product and Services
2.7.4 Thermo Fisher Scientific Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Thermo Fisher Scientific Recent Developments/Updates
2.8 ICON Plc
2.8.1 ICON Plc Details
2.8.2 ICON Plc Major Business
2.8.3 ICON Plc Biologics CDMO Product and Services
2.8.4 ICON Plc Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 ICON Plc Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Biologics CDMO Product and Services
2.9.4 Boehringer Ingelheim Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Boehringer Ingelheim Recent Developments/Updates
2.10 Fujifilm Diosynth Biotechnologies
2.10.1 Fujifilm Diosynth Biotechnologies Details
2.10.2 Fujifilm Diosynth Biotechnologies Major Business
2.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Product and Services
2.10.4 Fujifilm Diosynth Biotechnologies Biologics CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS CDMO BY MANUFACTURER
3.1 Global Biologics CDMO Sales Quantity by Manufacturer (2020-2025)
3.2 Global Biologics CDMO Revenue by Manufacturer (2020-2025)
3.3 Global Biologics CDMO Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Biologics CDMO by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Biologics CDMO Manufacturer Market Share in 2024
3.4.3 Top 6 Biologics CDMO Manufacturer Market Share in 2024
3.5 Biologics CDMO Market: Overall Company Footprint Analysis
3.5.1 Biologics CDMO Market: Region Footprint
3.5.2 Biologics CDMO Market: Company Product Type Footprint
3.5.3 Biologics CDMO Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics CDMO Market Size by Region
4.1.1 Global Biologics CDMO Sales Quantity by Region (2020-2031)
4.1.2 Global Biologics CDMO Consumption Value by Region (2020-2031)
4.1.3 Global Biologics CDMO Average Price by Region (2020-2031)
4.2 North America Biologics CDMO Consumption Value (2020-2031)
4.3 Europe Biologics CDMO Consumption Value (2020-2031)
4.4 Asia-Pacific Biologics CDMO Consumption Value (2020-2031)
4.5 South America Biologics CDMO Consumption Value (2020-2031)
4.6 Middle East & Africa Biologics CDMO Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics CDMO Sales Quantity by Type (2020-2031)
5.2 Global Biologics CDMO Consumption Value by Type (2020-2031)
5.3 Global Biologics CDMO Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics CDMO Sales Quantity by Application (2020-2031)
6.2 Global Biologics CDMO Consumption Value by Application (2020-2031)
6.3 Global Biologics CDMO Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Biologics CDMO Sales Quantity by Type (2020-2031)
7.2 North America Biologics CDMO Sales Quantity by Application (2020-2031)
7.3 North America Biologics CDMO Market Size by Country
7.3.1 North America Biologics CDMO Sales Quantity by Country (2020-2031)
7.3.2 North America Biologics CDMO Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Biologics CDMO Sales Quantity by Type (2020-2031)
8.2 Europe Biologics CDMO Sales Quantity by Application (2020-2031)
8.3 Europe Biologics CDMO Market Size by Country
8.3.1 Europe Biologics CDMO Sales Quantity by Country (2020-2031)
8.3.2 Europe Biologics CDMO Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics CDMO Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Biologics CDMO Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Biologics CDMO Market Size by Region
9.3.1 Asia-Pacific Biologics CDMO Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Biologics CDMO Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Biologics CDMO Sales Quantity by Type (2020-2031)
10.2 South America Biologics CDMO Sales Quantity by Application (2020-2031)
10.3 South America Biologics CDMO Market Size by Country
10.3.1 South America Biologics CDMO Sales Quantity by Country (2020-2031)
10.3.2 South America Biologics CDMO Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics CDMO Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Biologics CDMO Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Biologics CDMO Market Size by Country
11.3.1 Middle East & Africa Biologics CDMO Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Biologics CDMO Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Biologics CDMO Market Drivers
12.2 Biologics CDMO Market Restraints
12.3 Biologics CDMO Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics CDMO and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics CDMO
13.3 Biologics CDMO Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics CDMO Typical Distributors
14.3 Biologics CDMO Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF FIGURES
Table 1. Global Biologics CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biologics CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Group AG Major Business
Table 5. Lonza Group AG Biologics CDMO Product and Services
Table 6. Lonza Group AG Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Lonza Group AG Recent Developments/Updates
Table 8. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Samsung Biologics Major Business
Table 10. Samsung Biologics Biologics CDMO Product and Services
Table 11. Samsung Biologics Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Samsung Biologics Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biologics CDMO Product and Services
Table 16. AbbVie Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AbbVie Recent Developments/Updates
Table 18. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 19. WuXi Biologics Major Business
Table 20. WuXi Biologics Biologics CDMO Product and Services
Table 21. WuXi Biologics Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. WuXi Biologics Recent Developments/Updates
Table 23. Toyobo Basic Information, Manufacturing Base and Competitors
Table 24. Toyobo Major Business
Table 25. Toyobo Biologics CDMO Product and Services
Table 26. Toyobo Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Toyobo Recent Developments/Updates
Table 28. AGC Basic Information, Manufacturing Base and Competitors
Table 29. AGC Major Business
Table 30. AGC Biologics CDMO Product and Services
Table 31. AGC Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. AGC Recent Developments/Updates
Table 33. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 34. Thermo Fisher Scientific Major Business
Table 35. Thermo Fisher Scientific Biologics CDMO Product and Services
Table 36. Thermo Fisher Scientific Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Thermo Fisher Scientific Recent Developments/Updates
Table 38. ICON Plc Basic Information, Manufacturing Base and Competitors
Table 39. ICON Plc Major Business
Table 40. ICON Plc Biologics CDMO Product and Services
Table 41. ICON Plc Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. ICON Plc Recent Developments/Updates
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Biologics CDMO Product and Services
Table 46. Boehringer Ingelheim Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Boehringer Ingelheim Recent Developments/Updates
Table 48. Fujifilm Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 49. Fujifilm Diosynth Biotechnologies Major Business
Table 50. Fujifilm Diosynth Biotechnologies Biologics CDMO Product and Services
Table 51. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 53. Global Biologics CDMO Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 54. Global Biologics CDMO Revenue by Manufacturer (2020-2025) & (USD Million)
Table 55. Global Biologics CDMO Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 56. Market Position of Manufacturers in Biologics CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 57. Head Office and Biologics CDMO Production Site of Key Manufacturer
Table 58. Biologics CDMO Market: Company Product Type Footprint
Table 59. Biologics CDMO Market: Company Product Application Footprint
Table 60. Biologics CDMO New Market Entrants and Barriers to Market Entry
Table 61. Biologics CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Biologics CDMO Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 63. Global Biologics CDMO Sales Quantity by Region (2020-2025) & (K Units)
Table 64. Global Biologics CDMO Sales Quantity by Region (2026-2031) & (K Units)
Table 65. Global Biologics CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 66. Global Biologics CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 67. Global Biologics CDMO Average Price by Region (2020-2025) & (US$/Unit)
Table 68. Global Biologics CDMO Average Price by Region (2026-2031) & (US$/Unit)
Table 69. Global Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 70. Global Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 71. Global Biologics CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 72. Global Biologics CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 73. Global Biologics CDMO Average Price by Type (2020-2025) & (US$/Unit)
Table 74. Global Biologics CDMO Average Price by Type (2026-2031) & (US$/Unit)
Table 75. Global Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 76. Global Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 77. Global Biologics CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Global Biologics CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Global Biologics CDMO Average Price by Application (2020-2025) & (US$/Unit)
Table 80. Global Biologics CDMO Average Price by Application (2026-2031) & (US$/Unit)
Table 81. North America Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 82. North America Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 83. North America Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 84. North America Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 85. North America Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 86. North America Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 87. North America Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 88. North America Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 89. Europe Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 90. Europe Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 91. Europe Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 92. Europe Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 93. Europe Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 94. Europe Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 95. Europe Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 96. Europe Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Asia-Pacific Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 98. Asia-Pacific Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 99. Asia-Pacific Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 100. Asia-Pacific Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 101. Asia-Pacific Biologics CDMO Sales Quantity by Region (2020-2025) & (K Units)
Table 102. Asia-Pacific Biologics CDMO Sales Quantity by Region (2026-2031) & (K Units)
Table 103. Asia-Pacific Biologics CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 104. Asia-Pacific Biologics CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 105. South America Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 106. South America Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 107. South America Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 108. South America Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 109. South America Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 110. South America Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 111. South America Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 112. South America Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 113. Middle East & Africa Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 114. Middle East & Africa Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 115. Middle East & Africa Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Middle East & Africa Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Middle East & Africa Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 118. Middle East & Africa Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 119. Middle East & Africa Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 120. Middle East & Africa Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 121. Biologics CDMO Raw Material
Table 122. Key Manufacturers of Biologics CDMO Raw Materials
Table 123. Biologics CDMO Typical Distributors
Table 124. Biologics CDMO Typical Customers
LIST OF FIGURES
Figure 1. Biologics CDMO Picture
Figure 2. Global Biologics CDMO Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biologics CDMO Revenue Market Share by Type in 2024
Figure 4. Biological Agent Examples
Figure 5. Biosimilar Drug Examples
Figure 6. Global Biologics CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Biologics CDMO Revenue Market Share by Application in 2024
Figure 8. Cell Therapy Examples
Figure 9. Drug Development Examples
Figure 10. Others Examples
Figure 11. Global Biologics CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Biologics CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Biologics CDMO Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Biologics CDMO Price (2020-2031) & (US$/Unit)
Figure 15. Global Biologics CDMO Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Biologics CDMO Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Biologics CDMO by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Biologics CDMO Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Biologics CDMO Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Biologics CDMO Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Biologics CDMO Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Biologics CDMO Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Biologics CDMO Average Price by Type (2020-2031) & (US$/Unit)
Figure 30. Global Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Biologics CDMO Revenue Market Share by Application (2020-2031)
Figure 32. Global Biologics CDMO Average Price by Application (2020-2031) & (US$/Unit)
Figure 33. North America Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 45. France Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Biologics CDMO Consumption Value Market Share by Region (2020-2031)
Figure 53. China Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 56. India Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 73. Biologics CDMO Market Drivers
Figure 74. Biologics CDMO Market Restraints
Figure 75. Biologics CDMO Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Biologics CDMO in 2024
Figure 78. Manufacturing Process Analysis of Biologics CDMO
Figure 79. Biologics CDMO Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Table 1. Global Biologics CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biologics CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Lonza Group AG Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Group AG Major Business
Table 5. Lonza Group AG Biologics CDMO Product and Services
Table 6. Lonza Group AG Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Lonza Group AG Recent Developments/Updates
Table 8. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Samsung Biologics Major Business
Table 10. Samsung Biologics Biologics CDMO Product and Services
Table 11. Samsung Biologics Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Samsung Biologics Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biologics CDMO Product and Services
Table 16. AbbVie Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AbbVie Recent Developments/Updates
Table 18. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 19. WuXi Biologics Major Business
Table 20. WuXi Biologics Biologics CDMO Product and Services
Table 21. WuXi Biologics Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. WuXi Biologics Recent Developments/Updates
Table 23. Toyobo Basic Information, Manufacturing Base and Competitors
Table 24. Toyobo Major Business
Table 25. Toyobo Biologics CDMO Product and Services
Table 26. Toyobo Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Toyobo Recent Developments/Updates
Table 28. AGC Basic Information, Manufacturing Base and Competitors
Table 29. AGC Major Business
Table 30. AGC Biologics CDMO Product and Services
Table 31. AGC Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. AGC Recent Developments/Updates
Table 33. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 34. Thermo Fisher Scientific Major Business
Table 35. Thermo Fisher Scientific Biologics CDMO Product and Services
Table 36. Thermo Fisher Scientific Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Thermo Fisher Scientific Recent Developments/Updates
Table 38. ICON Plc Basic Information, Manufacturing Base and Competitors
Table 39. ICON Plc Major Business
Table 40. ICON Plc Biologics CDMO Product and Services
Table 41. ICON Plc Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. ICON Plc Recent Developments/Updates
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Biologics CDMO Product and Services
Table 46. Boehringer Ingelheim Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Boehringer Ingelheim Recent Developments/Updates
Table 48. Fujifilm Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 49. Fujifilm Diosynth Biotechnologies Major Business
Table 50. Fujifilm Diosynth Biotechnologies Biologics CDMO Product and Services
Table 51. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 53. Global Biologics CDMO Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 54. Global Biologics CDMO Revenue by Manufacturer (2020-2025) & (USD Million)
Table 55. Global Biologics CDMO Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 56. Market Position of Manufacturers in Biologics CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 57. Head Office and Biologics CDMO Production Site of Key Manufacturer
Table 58. Biologics CDMO Market: Company Product Type Footprint
Table 59. Biologics CDMO Market: Company Product Application Footprint
Table 60. Biologics CDMO New Market Entrants and Barriers to Market Entry
Table 61. Biologics CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Biologics CDMO Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 63. Global Biologics CDMO Sales Quantity by Region (2020-2025) & (K Units)
Table 64. Global Biologics CDMO Sales Quantity by Region (2026-2031) & (K Units)
Table 65. Global Biologics CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 66. Global Biologics CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 67. Global Biologics CDMO Average Price by Region (2020-2025) & (US$/Unit)
Table 68. Global Biologics CDMO Average Price by Region (2026-2031) & (US$/Unit)
Table 69. Global Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 70. Global Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 71. Global Biologics CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 72. Global Biologics CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 73. Global Biologics CDMO Average Price by Type (2020-2025) & (US$/Unit)
Table 74. Global Biologics CDMO Average Price by Type (2026-2031) & (US$/Unit)
Table 75. Global Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 76. Global Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 77. Global Biologics CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Global Biologics CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Global Biologics CDMO Average Price by Application (2020-2025) & (US$/Unit)
Table 80. Global Biologics CDMO Average Price by Application (2026-2031) & (US$/Unit)
Table 81. North America Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 82. North America Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 83. North America Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 84. North America Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 85. North America Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 86. North America Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 87. North America Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 88. North America Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 89. Europe Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 90. Europe Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 91. Europe Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 92. Europe Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 93. Europe Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 94. Europe Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 95. Europe Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 96. Europe Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Asia-Pacific Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 98. Asia-Pacific Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 99. Asia-Pacific Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 100. Asia-Pacific Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 101. Asia-Pacific Biologics CDMO Sales Quantity by Region (2020-2025) & (K Units)
Table 102. Asia-Pacific Biologics CDMO Sales Quantity by Region (2026-2031) & (K Units)
Table 103. Asia-Pacific Biologics CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 104. Asia-Pacific Biologics CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 105. South America Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 106. South America Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 107. South America Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 108. South America Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 109. South America Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 110. South America Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 111. South America Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 112. South America Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 113. Middle East & Africa Biologics CDMO Sales Quantity by Type (2020-2025) & (K Units)
Table 114. Middle East & Africa Biologics CDMO Sales Quantity by Type (2026-2031) & (K Units)
Table 115. Middle East & Africa Biologics CDMO Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Middle East & Africa Biologics CDMO Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Middle East & Africa Biologics CDMO Sales Quantity by Country (2020-2025) & (K Units)
Table 118. Middle East & Africa Biologics CDMO Sales Quantity by Country (2026-2031) & (K Units)
Table 119. Middle East & Africa Biologics CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 120. Middle East & Africa Biologics CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 121. Biologics CDMO Raw Material
Table 122. Key Manufacturers of Biologics CDMO Raw Materials
Table 123. Biologics CDMO Typical Distributors
Table 124. Biologics CDMO Typical Customers
LIST OF FIGURES
Figure 1. Biologics CDMO Picture
Figure 2. Global Biologics CDMO Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biologics CDMO Revenue Market Share by Type in 2024
Figure 4. Biological Agent Examples
Figure 5. Biosimilar Drug Examples
Figure 6. Global Biologics CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Biologics CDMO Revenue Market Share by Application in 2024
Figure 8. Cell Therapy Examples
Figure 9. Drug Development Examples
Figure 10. Others Examples
Figure 11. Global Biologics CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Biologics CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Biologics CDMO Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Biologics CDMO Price (2020-2031) & (US$/Unit)
Figure 15. Global Biologics CDMO Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Biologics CDMO Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Biologics CDMO by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Biologics CDMO Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Biologics CDMO Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Biologics CDMO Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Biologics CDMO Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Biologics CDMO Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Biologics CDMO Average Price by Type (2020-2031) & (US$/Unit)
Figure 30. Global Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Biologics CDMO Revenue Market Share by Application (2020-2031)
Figure 32. Global Biologics CDMO Average Price by Application (2020-2031) & (US$/Unit)
Figure 33. North America Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 45. France Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Biologics CDMO Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Biologics CDMO Consumption Value Market Share by Region (2020-2031)
Figure 53. China Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 56. India Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Biologics CDMO Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Biologics CDMO Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Biologics CDMO Consumption Value (2020-2031) & (USD Million)
Figure 73. Biologics CDMO Market Drivers
Figure 74. Biologics CDMO Market Restraints
Figure 75. Biologics CDMO Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Biologics CDMO in 2024
Figure 78. Manufacturing Process Analysis of Biologics CDMO
Figure 79. Biologics CDMO Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
